4/2014
5
Nucleotide-analogue-method-of-synthesis-of-nucleotide-r-nanalogue-use-of-nucleotide-analogue-antiviral-pro-nucleotide-r-npharmaceutical-composition,85,26435,0
abstract:</div><div>Short communication
Nucleotide analogue, method of synthesis of nucleotide analogue, use of nucleotide analogue, antiviral pro-nucleotide, pharmaceutical composition
h3>Adam Kraszewski, Joanna Romanowska, Agnieszka Szymańska-Michalak, MIchał Sobkowski, Jerzy Boryski, Jacek Stawiński, Andrzej Lipniacki, Andrzej Piasek</h3><div>vol. 95(4) C pp. 276-279 C 2014
4.56602">https://doi.org/10.5114/bta.2014.56602
a>View full text</a
26435
Kraszewski A, Romanowska J, Szymańska-Michalak A, et al. Nucleotide analogue, method of synthesis of nucleotide analogue, use of nucleotide analogue, antiviral pro-nucleotide, pharmaceutical composition. BioTechnologia. 2015;95(4):276-279. doi:10.5114/bta.2014.56602
Kraszewski, A., Romanowska, J., Szymańska-Michalak, A., Sobkowski, M., Boryski, J., &amp; Stawiński, J. et al. (2015). Nucleotide analogue, method of synthesis of nucleotide analogue, use of nucleotide analogue, antiviral pro-nucleotide, pharmaceutical composition. BioTechnologia, 95(4), 276-279. https://doi.org/10.5114/bta.2014.56602
Kraszewski, Adam, Joanna Romanowska, Agnieszka Szymańska-Michalak, MIchał Sobkowski, Jerzy Boryski, Jacek Stawiński, and Andrzej Lipniacki et al. 2015. "Nucleotide analogue, method of synthesis of nucleotide analogue, use of nucleotide analogue, antiviral pro-nucleotide, pharmaceutical composition". BioTechnologia 95 (4): 276-279. doi:10.5114/bta.2014.56602
Kraszewski, A., Romanowska, J., Szymańska-Michalak, A., Sobkowski, M., Boryski, J., Stawiński, J., Lipniacki, A., and Piasek, A. (2015). Nucleotide analogue, method of synthesis of nucleotide analogue, use of nucleotide analogue, antiviral pro-nucleotide, pharmaceutical composition. BioTechnologia, 95(4), pp.276-279. https://doi.org/10.5114/bta.2014.56602
Kraszewski, Adam et al. "Nucleotide analogue, method of synthesis of nucleotide analogue, use of nucleotide analogue, antiviral pro-nucleotide, pharmaceutical composition." BioTechnologia, vol. 95, no. 4, 2015, pp. 276-279. doi:10.5114/bta.2014.56602
Kraszewski A, Romanowska J, Szymańska-Michalak A, Sobkowski M, Boryski J, Stawiński J et al. Nucleotide analogue, method of synthesis of nucleotide analogue, use of nucleotide analogue, antiviral pro-nucleotide, pharmaceutical composition. BioTechnologia. 2015;95(4):276-279. doi:10.5114/bta.2014.56602
null
The object of the invention are 1) nucleotide analogues, 2) antiviral pro-nucleotides, 3) a use of nucleotide analogues and pharmaceutical composition, 4) a phosphorylating agent for synthesis of nucleotide analogue, and 5) a method of synthesis of nucleotide analogues. More precisely, the invention applies to the new group of nucleotide analogues and their use in partial or complete inhibition of human immunodeficiency virus (HIV).</div
